Testing a new peritoneal dialysis fluid for kidney failure
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This Phase 3 trial studies how well a new peritoneal dialysis solution works and whether it is safe. It’s meant for adults with kidney failure who already do a specific type of at-home dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- You have kidney failure (ESRD) and used CAPD at home in the last 3 months
- You have not had peritonitis (a serious stomach/lining infection) in the last 3 months
- You’ve been using Extraneal (a nighttime dialysis fluid) for at least 1 month, and one specific daytime dialysis fluid
- Your recent kidney dialysis performance is strong (Kt/V urea greater than 1.7 per week)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to do hemodialysis to better remove waste products that build up in the blood. It may help improve dialysis treatment for people with kidney failure.
This study compares two forms of home peritoneal dialysis—how well they work for kidney health and how they affect daily life. You may be considered if you have end-stage kidney disease and meet specific test and safety requirements.
This trial tests if adjusting the salt (sodium) in your dialysis fluid can improve your health. It is for people on dialysis who have trouble with too much fluid gain or high blood pressure between sessions.
This trial tests a special peritoneal dialysis solution with amino acids (protein building blocks) to improve nutrition in people on CAPD who are malnourished. It might help boost your protein levels and overall health.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This trial tests a new device called WEAKID for people on peritoneal dialysis. It aims to see if the device is safe to use. Participants must have been on PD for at least 3 months and have no recent infections or catheter problems.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.